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ABSTRACT
Objective: To evaluate the effects of intravenous fluid
bolus compared to maintenance intravenous fluids
alone as part of immediate emergency care in children
with severe febrile illness and signs of impaired
circulation in low-income settings.
Design: Systematic review of randomised controlled
trials (RCTs), and observational studies, including
retrospective analyses, that compare fluid bolus
regimens with maintenance fluids alone. The primary
outcome measure was predischarge mortality.
Data sources and synthesis: We searched PubMed,
The Cochrane Library (to January 2014), with
complementary earlier searches on, Google Scholar
and Clinical Trial Registries (to March 2013). As
studies used different clinical signs to define impaired
circulation we classified patients into those with signs
of severely impaired circulation, or those with any
signs of impaired circulation. The quality of evidence
for each outcome was appraised using the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) approach. Findings are presented
as risk ratios (RRs) with 95% CIs.
Results: Six studies were included. Two were RCTs,
one large trial (n=3141 children) from a low-income
country and a smaller trial from a middle-income
country. The remaining studies were from middle-
income or high-income settings, observational, and
with few participants (34–187 children).
Severely impaired circulation: The large RCT
included a small subgroup with severely impaired
circulation. There were more deaths in those receiving
bolus fluids (20–40 mL/kg/h, saline or albumin)
compared to maintenance fluids (2.5–4 mL/kg/h; RR
2.40, 95% CI 0.84 to 6.88, p=0.054, 65 participants,
low quality evidence). Three additional observational
studies, all at high risk of confounding, found mixed
effects on mortality (very low quality evidence).
Any signs of impaired circulation: The large RCT
included children with signs of both severely and non-
severely impaired circulation. Overall, bolus fluids
increased 48 h mortality compared to maintenance
fluids with an additional 3 deaths per 100 children
treated (RR 1.45, 95% CI 1.13 to 1.86, 3141
participants, high quality evidence). In a second small
RCT from India, no difference in 72 h mortality was
detected between children who received 20–40 mL/kg
Ringers lactate over 15 min and those who received
20 mL over 20 min up to a maximum of 60 mL/kg over
1 h (147 participants, low quality evidence). In one
additional observational study, resuscitation consistent
with Advanced Paediatric Life Support (APLS)
guidelines, including fluids, was not associated with
reduced mortality in the small subgroup with septic
shock (very low quality evidence).
Signs of impaired circulation, but not severely
impaired: Only the large RCT allowed an analysis for
children with some signs of impaired circulation who
would not meet the criteria for severe impairment.
Bolus fluids increased 48 h mortality compared to
maintenance alone (RR 1.36, 95% CI 1.05 to 1.76,
high quality evidence).
Conclusions: Prior to the publication of the large
RCT, the global evidence base for bolus fluid therapy
in children with severe febrile illness and signs of
impaired circulation was of very low quality. This large
study provides robust evidence that in low-income
settings fluid boluses increase mortality in children
with severe febrile illness and impaired circulation, and
this increased risk is consistent across children with
severe and less severe circulatory impairment.
Strengths and limitations of this study
▪ Timely systematic review given the current
uncertainty on optimal strategy for fluid resusci-
tation in children; review incorporates data on
the largest randomised controlled trial (RCT;
Fluid Expansion as Supportive Therapy trial) of
fluid therapy in children.
▪ Review includes all relevant comparative trials
and observational data, and critically appraises
the research evidence using Grading of
Recommendations Assessment, Development
and Evaluation (GRADE) methods.
▪ Review is limited because most studies are small
and unreliable, with only one large RCT provid-
ing reliable data to guide policy.
Opiyo N, Molyneux E, Sinclair D, et al. BMJ Open 2014;4:e004934. doi:10.1136/bmjopen-2014-004934 1
Open Access Research
 group.bmj.com on May 20, 2014 - Published by bmjopen.bmj.comDownloaded from 
BACKGROUND
Health staff must rapidly assess, resuscitate and treat
severely ill children to improve survival. Practical, simple
to use protocols have been established to guide care. In
North America, the most commonly used are the
Pediatric Advanced Life Support (PALS)1 and in
Europe, the European Paediatric Life Support (EPLS)2
guidelines. In low-income settings, the WHO has speciﬁc
guidelines where there are no intensive care facilities,
called the Emergency Triage Assessment and Treatment
(ETAT) guidelines. ETAT guidance begins with initial
triage to identify children who need urgent formal
assessment such as altered consciousness or severe
breathing or circulation problems. Immediate care
should then follow an Airway, Breathing, Circulation,
Drugs (ABCD) approach to assessment and action
which prioritises care of the airway (A) ﬁrst, followed by
breathing (B) and circulation (C).
Septic shock
Severe febrile illness in children is often associated with
signs of impaired circulation (also known as ‘septic
shock’). Current ETAT guidelines deﬁne shock as the
presence of three clinical signs of poor peripheral perfu-
sion: weak/absent peripheral pulse, prolonged capillary
reﬁlling >3 s and cold hands and feet (typically with cold
skin extending up the limb and termed ‘a temperature
gradient’). International guidance, including ETAT, typ-
ically recommends a rapid ﬂuid bolus of 20–40 mL/kg
intravenously once ‘shock’ is diagnosed.3
Why it is important to do this review
As early as 1999, authors were arguing that no robust
data existed demonstrating that bolus ﬂuid resuscitation
improved clinical outcomes in septic patients.4
Moreover, the results of observational studies suggested
that large volumes of resuscitation ﬂuids may be asso-
ciated with increased morbidity in patients with sepsis5
acute respiratory distress syndrome6 or acute kidney
injury.7
Subsequently, a large, multicentre, randomised con-
trolled trial (RCT) published in 2011, and conducted in
East Africa found that bolus ﬂuid resuscitation increased
mortality compared to a maintenance ﬂuid regimen in
children with ‘febrile illness’ and impaired perfusion.8
The results of this trial clashed with the long-standing
belief that ﬂuid bolus resuscitation was beneﬁcial and
caused considerable international debate.9–12 To date,
no clear guidance has emerged on how to incorporate
these ﬁndings into recommendations for practice in
high-income or low-income settings.
OBJECTIVE
To evaluate the effects of ﬂuid bolus (with either col-
loids or crystalloids) compared to maintenance ﬂuids
alone in children with severe febrile illness and signs
of impaired circulation.
METHODS
Criteria for considering studies for this review
Types of studies
RCTs and observational studies, including retrospective
analyses.
Types of participants
Children (aged ≤18 years) with clinical features suggest-
ing impaired perfusion (including shock) due to pre-
sumed acute infectious illnesses or inﬂammatory state
(sepsis) and excluding diarrhoeal illness (as deﬁned by
the studies).
Types of interventions
Intravenous ﬂuid boluses (crystalloids or colloids) com-
pared to no (or lower volume) ﬂuid boluses or mainten-
ance ﬂuids.
Types of outcome measures
The primary outcome measure was predischarge mortal-
ity. Secondary outcomes were: mortality at any time up
to 4 weeks and any adverse clinical events reported in
the studies.
Data sources and search strategy
We searched PubMed, The Cochrane Library to January
2014, complemented by searches in Google Scholar and
Clinical Trial Registries (ClinicalTrials.gov, Current
Controlled Trials, WHO International Clinical Trials
Registry Platform, metaRegister of Controlled Trials) to
March 2013. We sought eligible published, unpublished
or in-progress articles. No date or language restrictions
were used.
The searches were performed iteratively by combining
Medical Subject Headings (MeSH) and free-text terms
relevant to the conditions (sepsis, septicaemia, febrile
illness, bacteraemia, infection, meningitis, septic shock,
hypovolaemia), treatments (ﬂuids, resuscitation, intra-
venous ﬂuids, ﬂuid therapy) and patient groups (neo-
nates, infants, children, adolescents) of interest. No date
or language restrictions were used.
In addition we searched the websites of relevant orga-
nisations (the International Sepsis Forum, the World
Federation of Paediatric Intensive Care and Critical Care
Societies) and key emergency/intensive care journals
(Critical Care Medicine, Critical Care, Paediatric
Emergency Medicine, Shock, Resuscitation, Intensive
Care Medicine). Reference lists of related systematic
reviews and primary studies were manually searched. We
also sought additional papers by contacting authors of
related reviews and selected studies.
Study selection
Two reviewers (NO and ME) independently screened
the titles, abstracts and full texts of retrieved articles
and applied the study eligibility criteria detailed
above to select studies. Disagreements were resolved by
discussion.
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Data extraction
Data were extracted using a predesigned form by one
reviewer (NO) and checked by the other reviewers; dis-
agreements were resolved by discussion. We extracted
data on: study designs, settings, sample size, participants
(diagnoses, age range), shock deﬁnitions, treatments
and comparisons (types of ﬂuids, timing, volumes and
ﬂuid rates), cointerventions and proportion of patients
experiencing the events of interest in each treatment
group.
Risk of bias in individual studies
Two reviewers (NO and DS) independently assessed the
risk of bias in the included studies according to six cri-
teria assessing the risk of selection bias (random
sequence generation, allocation concealment, selection
of two groups), reporting bias (blinding) and confound-
ing (baseline characteristics, cointerventions). For each
criteria, the study was classiﬁed as high risk of bias, low
risk of bias or unclear risk of bias.
Assessment of quality of evidence
The quality of evidence for each of the efﬁcacy and
safety outcomes was assessed using the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) approach.13 Key quality elements
assessed by GRADE include: risk of bias (study limita-
tions), precision of treatment effects, consistency of
results, directness (applicability) of evidence and publi-
cation bias. The GRADE evidence proﬁles were pre-
pared by one reviewer (NO) and veriﬁed independently
by two reviewers (ME and DS). Discrepancies in the
quality ratings were resolved by discussion.
Synthesis of results
We summarised results narratively due to signiﬁcant dif-
ferences in study designs, ﬂuid protocols and patient
risk proﬁles. In order to compare studies with similar
populations we grouped studies by the severity of circula-
tory impairment at baseline, after an appraisal of the
clinical signs used to deﬁne inclusion. We deﬁned three
groups (table 1):
1. Severely impaired circulation (SIC): Studies where inclu-
sion criteria were similar to the ETAT guidance
(shock deﬁned as presence of all four signs of
impaired circulation).
2. Impaired circulation (IC): Studies where inclusion only
required one or two of these signs.
3. IC but without severe impairment: Studies where inclu-
sion required one or two signs of IC and more
severely ill patients were excluded.
For consistency all results are presented as risk ratios
(RRs) with 95% CIs (where reported, odds ratios and
percentage point differences were converted into RRs).
RESULTS
Study selection process
The ﬂow of studies through this review is summarised in
ﬁgure 1. Six studies fulﬁlled all our prespeciﬁed eligibil-
ity criteria: two RCTs,8 14 two prospective cohort
studies15 16 and two retrospective record reviews.17 18
Study characteristics
The characteristics of the six included studies are sum-
marised in online supplementary table S1. Study settings
were varied: USA,15–17 Brazil,18 India14 and East Africa
(Kenya, Tanzania and Uganda).8 Five studies14–18 were
conducted in settings where paediatric intensive care
unit facilities including inotropic support, intubation
and ventilation were available. The largest study8 was
conducted in typical resource-limited East African hospi-
tals without these additional measures being available.
The study sample sizes ranged from 34 to 3141 patients.
The clinical deﬁnitions of severe febrile illness and cir-
culatory impairment or ‘shock’ varied across studies
Table 1 Severity of circulatory impairment classifications
Clinical group Definition
SIC Children with severe febrile illness who have all four of the following features:
▸ AVPU<A
▸ Weak/absent peripheral pulse
▸ Prolonged capillary refilling >3 s
▸ Cold limb extremities (hands and feet) typically with cold skin extending up the limb (referred to as a
temperature gradient)
These children typically also have secondary signs such as altered consciousness
IC Children with severe febrile illness who may have AVPU<A, or prostration or respiratory distress plus at
least ONE of the following features are included in this group:
▸ Weak peripheral pulse
▸ Capillary refilling >2 s
▸ Cold limb extremities with a temperature gradient
▸ Severe tachycardia (>180/min if aged 2–12 m, >160/min if aged 1–4 years)
IC but without
SIC
By exclusion a third clinical grouping can be defined, those withimpaired circulation but without severe
impairment
AVPU, Alert, responsive to Verbal, Painful stimuli, or Unresponsive; IC, impaired circulation; SIC, severely impaired circulation.
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(table 2). Fluid therapy protocols (volumes, timing,
rates) were similarly varied between comparison study
groups (see online supplementary table S1). In only one
case, the work conducted in East Africa, was a clearly
deﬁned ‘no bolus’ group studied.8
Risk of bias
Both RCTs were considered to be of low risk of bias
(table 3). The observational studies were all potentially con-
founded (none met all the risk of bias criteria; table 3).
The following key criteria were only partially met or were
unclear from the information provided: appropriate par-
ticipant selection, study power, appropriate blinding/
outcome assessments and association of outcome and
treatment.
Outcomes
The results for the efﬁcacy and safety outcomes,
together with quality of evidence, are summarised in the
following three distinct population risk groups.
A. Children with severe febrile illness and signs of SIC
Four studies reported outcome data in children rele-
vant to those with SIC: one RCT,8 one prospective
cohort16 and two retrospective studies.17 18 Overall mor-
tality in the patients reported in these analyses were:
42%, 51%, 29% and 47%, respectively.
Trial data: The RCT8 included children with milder
forms of circulatory impairment but provided a sub-
group analysis of 65 patients who fulﬁlled the ETAT
criteria of ‘shock’. In this subgroup a ﬂuid bolus of
20–40 mL/kg (saline or albumin) over 1 h was asso-
ciated with a considerably higher risk of mortality than
maintenance ﬂuids (2–4 mL/kg/h) but this was of bor-
derline statistical signiﬁcance (RR 2.40, 95% CI 0.84 to
6.88, p=0.054, low quality evidence; see online supplemen-
tary tables S2 and S3).
Observational data: In Brazil a retrospective records
review of 90 children admitted to a paediatric intensive
care unit with sepsis and shock assessed the relationship
between mortality and ﬂuid resuscitation in the ﬁrst
hour.18 Administration of 20 mL/kg of bolus resuscita-
tion ﬂuid (crystalloids, colloids) was associated with a sig-
niﬁcantly higher mortality than if 40 mL/kg or more
was given (73% vs 33%, RR 0.45, 95% CI not estimable,
p<0.05, very low quality evidence; see online supplementary
tables S2 and S3). Of particular note 80 of the 90 chil-
dren studied had severe, pre-existing chronic disease
such as malignancy.
A second retrospective records review from the USA,
examined mortality in 91 children being resuscitated
and referred by community physicians.17 In this study
‘appropriate ﬂuid therapy’ was reported to be strongly
associated with improved survival (RR 0.20, 95% CI 0.05
to 0.78, very low quality evidence; see online supplementary
tables S2 and S3). However, the ‘appropriate ﬂuid
therapy’ group included those with ﬂuids given as per
guidelines and children in whom signs of shock resolved
quickly irrespective of the volumes of ﬂuid given. In fact,
the median ﬂuid volumes given to children who died
(32.9 mL/kg) were higher than those given to survivors
(20 mL/kg).
The third study, a prospective cohort from the USA,
included 34 children admitted to the paediatric inten-
sive care unit with microbiologically proven septic shock,
and all were receiving inotropes and had a pulmonary
catheter inserted.16 Those receiving less than 20 mL/kg
of ﬂuids during the ﬁrst hour of resuscitation (normal
saline, Ringers lactate, 5% albumin) had signiﬁcantly
higher mortality than those given 20–40 mL/kg of ﬂuids
(RR 1.11, 95% CI 0.59 to 2.11, very low quality evidence)
or more than 40 mL/kg (RR 0.19, 95% CI 0.03 to 1.30,
very low quality evidence; see online supplementary tables
S2 and S3).
B. Children with severe febrile illness and any sign of IC
Two RCTs8 14 and one prospective cohort study15
enrolled febrile children with clinical signs sufﬁciently
similar to be included in the IC category. Overall mortal-
ity in the patients reported in these studies were 9.5%,
18% and 12.5%, respectively.
Trial data: In the largest RCT from Africa 3141 chil-
dren were randomised to a ﬂuid bolus (20–40 mL/kg
albumin or normal saline over 1 h) or maintenance
ﬂuids (2.5–4.0 mL/kg/h).8 Compared to maintenance
ﬂuids, the ﬂuid bolus was associated with increased 48 h
mortality (RR 1.45, 95% CI 1.13 to 1.86, high quality evi-
dence; see online supplementary tables S4 and S5) and
increased mortality at 4 weeks (RR 1.39, 95% CI 1.11 to
1.74, moderate quality evidence; see online supplementary
tables S4 and S5). There was no suggestion that albumin
performed any differently than saline (albumin bolus vs
saline bolus, RR 1.0, 95% CI 0.78 to 1.29). There was no
difference between the bolus and maintenance ﬂuid
groups in the risk of neurological sequelae at 4 weeks
(RR 1.03, 95% CI 0.61 to 1.75, low quality evidence; see
online supplementary tables S4 and S5) or the com-
bined outcome of pulmonary oedema or increased
intracranial pressure (RR 1.46, 95% CI 0.85 to 2.53, low
quality evidence; see online supplementary tables S4 and
Figure 1 Results of literature search and studies selected.
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Table 2 Study inclusion criteria
Study population entry
criteria ‘Shock’ criteria
Study Age range Severe illness Blood
pressure
Pulse rate Capillary
refill
Extremities Peripheral
pulse
Urine
output
Mental
status
Maitland
2011
60 days to
12 years
Severe febrile
illness
complicated by
impaired
consciousness
(prostration or
coma),
respiratory
distress
(increased work
of breathing) or
both
and – or Severe
tachycardia*
or ≥3 s or Lower limb
temperature
gradient
or Weak
radial
pulse
volume
– – – –
Oliveira
2008
Median age:
36–47
months
Sepsis was
defined using
the Society of
Critical Care
Medicine
Consensus
Conference22
and <5th
centile
for age
or – or <1 s or
>3 s
or Mottled/cool or Decreased or <1 mL/kg/h or Altered
Han 2003 1–131
months
Suspected
infection as
manifested by
hyperthermia or
hypothermia
and <5th
centile
for age
or – or >3 s or Mottled or Diminished or – Decreased
Carcillo
1991
Median age
13.5 months
(range 1–
192 months)
Sepsis was
diagnosed if the
patient had a
positive blood
culture or if a
pathological
organism from
a tissue site
was identified
and <2 SD
below
mean
+
3
of
Tachycardia† or – or Mottled/cool or Decreased or <1 mL/kg/
h‡
– –
Santhanam
2008
1–12 months Septic shock
was defined
and – or Tachycardia >2 s or Mottled/cool or Decreased or Decreased or Altered
alertness
Continued
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S5). A subgroup analysis suggested that the increased
mortality was only statistically signiﬁcant in children with
severe anaemia (haemoglobin <5 g/dL; RR 1.71, 95% CI
1.16 to 2.51, moderate-quality evidence; see online supple-
mentary tables S4 and S5), but a subsequent analysis
exploring the effect of anaemia when treated as a con-
tinuous variable found evidence of harm with ﬂuid
bolus across the full range of haemoglobin values.19
In the second RCT, 147 children in an Indian paediat-
ric intensive care unit were randomised to receive
Ringers lactate 20–40 mL/kg over 15 min or Ringers
lactate 20 mL/kg over 20 min up to a maximum of
60 mL/kg over 1 h.14 There was no difference in 72 h
mortality between comparison groups (RR 0.99, 95% CI
0.49 to 1.98, low quality evidence; see online supplemen-
tary tables S4 and S5).
Observational data: The prospective cohort study
included 1409 children but only 187 had septic shock
and so were relevant to this review.15 No difference in
mortality was observed in this subgroup between those
receiving resuscitation consistent with PALS/Advanced
Paediatric Life Support recommendations (including
rapid bolus 20 mL/kg of isotonic ﬂuid, potentially
repeated and use of inotropes) performed by commu-
nity physicians compared to resuscitation not consistent
with these recommendations (very low quality evidence; see
online supplementary tables S4 and S5). In addition,
the actual ﬂuid volumes administered and the relation-
ship between ﬂuid volumes given and outcomes is not
presented. Furthermore, resuscitation episodes were
classiﬁed as having been consistent with guidelines if
signs of shock resolved early in the course of interven-
tion, irrespective of actual ﬂuid volumes given.
C. Children with severe febrile illness and IC but not
SIC
It was possible to derive outcome data for children
with severe febrile illness and any sign of circulatory
impairment (IC) but not SIC in one study20: 20–40 mL/kg
bolus ﬂuids (albumin, normal saline) provided over 1 h,
compared to 2.5–4.0 mL/kg/h maintenance ﬂuids, was
associated in this large subgroup (n=3076 children) with
increased 48-h mortality (RR 1.36, 95% CI 1.05 to 1.76,
high quality evidence).
DISCUSSION
This review was conducted to facilitate revision of
national paediatric ﬂuid management guidelines in
Kenya and potentially neighbouring countries using
ETAT guidance, but has direct policy implications for
healthcare across Africa.
The limited data available prior to the Fluid
Expansion as Supportive Therapy (FEAST) study dem-
onstrate that the current recommendations for ﬂuid
bolus included in the ETAT guidelines were not sup-
ported by a strong scientiﬁc evidence base. In fact, the
evidence was largely observational and unreliable.
Added to this, the studies were themselves ﬂawed, with
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design aspects which potentially biased the result
towards favouring high-volume ﬂuid resuscitation. Of
particular note are two of the retrospective studies which
classiﬁed all children who recovered quickly as having
received ‘adequate ﬂuid therapy’ irrespective of the
ﬂuid volume they received. The potential for bias in
these studies resulting from possible exposure misclassiﬁ-
cation should be noted by paediatricians working in
high-resource settings.
The RCT published in 2011 provides by far the most
direct assessment of ﬂuid boluses in children with severe
febrile illness in resource poor African settings that do
not typically see dengue fever but where malaria may be
common.8 In these settings emergency management
decisions must typically be made without accurate blood
pressure reading or investigations such as pulse oxim-
etry, blood gas analysis, haemoglobin or lactate measure-
ment. The robust ﬁnding of increased mortality in the
large group of children with an initial, clinical diagnosis
of severe febrile illness and IC but not SIC demonstrates
that the clinical signs linked to this classiﬁcation are,
alone, not sufﬁcient to identify children in whom ﬂuid
boluses may be beneﬁcial. In fact this trial provides
robust evidence that bolus intravenous ﬂuids are
harmful in such children.
Data from the small subgroup of children within the
FEAST study who had all three clinical signs of SIC, are
the only randomised evidence on the risks and beneﬁts
of ﬂuid boluses for this group. Mortality among those
receiving bolus ﬂuids was higher than those receiving
maintenance ﬂuids but the data are compatible with an
effect ranging from a small potential beneﬁt of bolus to
very substantial harm, which raises severe doubt about
the use of boluses even in this more severely ill group.
In an effort to accommodate the highly inﬂuential
observational research on ﬂuid use in paediatric emer-
gency care we included data from studies traditionally
excluded from systematic reviews of alternative therapies
(such as the recent review by Ford et al21). Although this
presented challenges it is an advantage of the GRADE
approach that the quality of evidence from such studies
can be transparently appraised and, potentially there-
fore, contribute to informed decision-making.
CONCLUSION
Prior to the publication of the large multicentre African
RCT, the evidence in support of aggressive ﬂuid therapy
in children with septic shock was only of very low quality.
The 2011 RCT provides robust evidence that in low-
resource settings ﬂuid boluses, even in relatively small
amounts, increase mortality in children with severe
febrile illness and signs of IC. For children with signs of
SIC the evidence suggests harm but there is less cer-
tainty and further research is warranted.
Author affiliations
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Table 3 Quality assessment of included studies
Study design
Selection bias
Reporting
bias Confounding
Study
Random
sequence
generation
Allocation
concealment
Selection
of two
groups Blinding
Baseline
characteristics
Co-
interventions
Maitland et al8 Randomised
controlled trial
Low risk Low risk Low risk Low risk Low risk Low risk
Santhanam
et al14
Randomised
controlled trial
Low risk Low risk Low risk Low risk Low risk Low risk
Carcillo et al15 Prospective
cohort
NA NA High risk* NA High risk* Unclear risk
Oliveira et al18 Retrospective
records review
NA NA High risk† NA High risk† Unclear risk
Han et al17 Retrospective
records review
NA NA High risk‡ NA High risk‡ Unclear risk
Carcillo et al16 Prospective
cohort
NA NA Low risk NA Unclear risk§ Unclear risk
*Compared those who received recommended APLS/PALS treatment with those who did not. ‘Received recommended APLS/PALS fluid
therapy’ was defined as those who recovered regardless of fluid therapy plus those who did not recover but received >20 mg/kg of fluids.
Children who did not receive recommended APLS/PALS treatment were significantly younger and had significantly longer capillary refill times,
lower blood pressure and higher oxygen requirements.
†Compared survivors and non-survivors. The survivors were more likely to have had higher fluid volumes and were also significantly younger.
‡Compared survivors and non-survivors. ‘Appropriate fluid therapy’ group includes those where fluid was given in line with ACCM/PALS
guidelines AND those who recovered quickly irrespective of how much fluid was given. Non-survivors had significantly higher PRISM scores
at baseline (PRISM assesses the risk of mortality).
§Compared those who received three different fluid regimens. Adequate baseline characteristics were not presented.
APLS, Advanced Paediatric Life Support; NA, not applicable; PALS, Pediatric Advanced Life support.
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